Sight Sciences (SGHT) Change in Account Payables (2020 - 2026)
Sight Sciences' (SGHT) quarterly Change in Account Payables came in at $143000.0 in Q1 2026, down 86.67% year-on-year from $1.1 million in Q1 2025, and up 135.93% quarter-over-quarter from -$398000.0 in Q4 2025.
Sight Sciences (SGHT) Change in Account Payables (2020 - 2026) Analysis & Trends
Sight Sciences' Change in Account Payables history runs 7 years deep, the most recent figure standing at $143000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 86.67% year-over-year to $143000.0 in Q1 2026; TTM through Mar 2026 was -$1.3 million, a 223.12% decrease from a year earlier, with the FY2025 full-year figure at -$348000.0, down 203.57% from the prior year.
- Change in Account Payables climbed to $143000.0 in Q1 2026 per SGHT's latest filing, from -$398000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.1 million in Q1 2025 and bottomed at -$1.7 million in Q4 2023.
- The 5-year median for Change in Account Payables is -$248000.0 (2022), against an average of -$85058.8.
- Across the five-year window, Change in Account Payables jumped 454.03% in 2023 and slumped 368.75% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at -$617000.0 in 2022, then sank by 179.42% to -$1.7 million in 2023, then soared by 121.87% to $377000.0 in 2024, then sank by 205.57% to -$398000.0 in 2025, then soared by 135.93% to $143000.0 in 2026.
- Per Business Quant, the three latest SGHT Change in Account Payables figures stand at $143000.0 (Q1 2026), -$398000.0 (Q4 2025), and -$335000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | 143,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,000.00 |
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | -398,000.00 |
| Dec 31, 2025 | -398,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Mar 31, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 377,000.00 |
| Dec 31, 2024 | 377,000.00 |
| Sep 30, 2024 | -668,000.00 |
| Sep 30, 2024 | -668,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | -1.72 Mn |
| Dec 31, 2023 | -1.72 Mn |